OSELLA, Domenico
 Distribuzione geografica
Continente #
EU - Europa 11.052
NA - Nord America 10.328
AS - Asia 5.572
SA - Sud America 887
AF - Africa 176
Continente sconosciuto - Info sul continente non disponibili 25
OC - Oceania 5
Totale 28.045
Nazione #
US - Stati Uniti d'America 10.153
RU - Federazione Russa 2.631
IE - Irlanda 2.354
SG - Singapore 1.699
SE - Svezia 1.688
CN - Cina 1.534
DE - Germania 1.471
UA - Ucraina 1.109
HK - Hong Kong 885
VN - Vietnam 739
BR - Brasile 681
FI - Finlandia 657
FR - Francia 368
IT - Italia 358
GB - Regno Unito 217
IN - India 213
KR - Corea 113
CA - Canada 109
AR - Argentina 86
BD - Bangladesh 58
BJ - Benin 52
MX - Messico 52
ID - Indonesia 47
PL - Polonia 44
IR - Iran 42
TR - Turchia 39
ZA - Sudafrica 39
BE - Belgio 33
EC - Ecuador 33
JP - Giappone 33
IQ - Iraq 27
ES - Italia 23
EU - Europa 23
UZ - Uzbekistan 23
CO - Colombia 20
NL - Olanda 20
AT - Austria 19
CL - Cile 18
PY - Paraguay 18
MA - Marocco 17
PK - Pakistan 15
LT - Lituania 14
SA - Arabia Saudita 14
TH - Thailandia 13
VE - Venezuela 13
EG - Egitto 12
RO - Romania 12
KE - Kenya 11
TN - Tunisia 11
PH - Filippine 10
DZ - Algeria 9
NP - Nepal 8
UY - Uruguay 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
JO - Giordania 7
ET - Etiopia 6
HR - Croazia 6
IL - Israele 6
TW - Taiwan 6
AU - Australia 5
AZ - Azerbaigian 5
BO - Bolivia 5
KG - Kirghizistan 4
KZ - Kazakistan 4
NG - Nigeria 4
PA - Panama 4
PS - Palestinian Territory 4
CI - Costa d'Avorio 3
GR - Grecia 3
OM - Oman 3
PE - Perù 3
QA - Qatar 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BW - Botswana 2
CG - Congo 2
CZ - Repubblica Ceca 2
HU - Ungheria 2
LB - Libano 2
LV - Lettonia 2
NO - Norvegia 2
PR - Porto Rico 2
PT - Portogallo 2
RE - Reunion 2
RS - Serbia 2
SI - Slovenia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CM - Camerun 1
CR - Costa Rica 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
Totale 28.034
Città #
Dublin 2.347
Jacksonville 1.880
Dearborn 984
Hong Kong 877
Chandler 805
Singapore 738
San Jose 609
Ashburn 572
Wilmington 572
Beijing 502
Moscow 401
Lawrence 319
Princeton 319
Lauterbourg 289
Ann Arbor 255
San Mateo 253
Ho Chi Minh City 244
Los Angeles 231
Andover 202
New York 200
Buffalo 158
Hanoi 155
Piemonte 133
Seoul 108
Munich 102
Boardman 99
Woodbridge 93
Houston 90
Düsseldorf 89
Philadelphia 82
São Paulo 73
Toronto 65
Orem 64
Redondo Beach 59
Bremen 58
Guangzhou 53
Cotonou 52
Dallas 52
Grafing 49
Hefei 47
Nanjing 47
Helsinki 46
Santa Clara 42
Norwalk 41
Frankfurt am Main 40
Kunming 36
Tianjin 34
Atlanta 33
Chennai 33
Da Nang 33
Brussels 32
Tokyo 30
Warsaw 30
Monmouth Junction 28
Chicago 27
Leawood 27
Denver 26
Shanghai 25
Stockholm 25
Hangzhou 24
Haiphong 23
Montreal 23
Rio de Janeiro 23
Biên Hòa 21
Fairfield 21
Tashkent 21
Brooklyn 20
London 20
Novara 20
Manchester 19
Mumbai 19
Poplar 19
Zanjan 19
Mexico City 18
Shenzhen 18
Belo Horizonte 17
Nuremberg 17
Ankara 16
Cave Creek 16
Jinan 16
Johannesburg 16
Phoenix 16
Turku 16
Hải Dương 15
Hebei 14
Ardabil 13
Bexley 13
Boston 13
Seattle 13
Shenyang 13
Curitiba 12
Quito 12
Zhengzhou 12
Amsterdam 11
Augusta 11
Brasília 11
Fuzhou 11
Guarulhos 11
Jakarta 11
Kocaeli 11
Totale 15.580
Nome #
Antiproliferative Activity of Pt(IV) Conjugates Containing the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Ketoprofen and Naproxen 160
Cisplatin and valproate released from the bifunctional [Pt(IV)Cl2(NH3)2(valproato)2] antitumor prodrug or from liposome formulations: who does what? 154
Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells 149
195Pt NMR chemical shift: a chemometric approach 145
Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs 142
Transition metal carbonyl clusters in biology: A futile or niche research area? 142
Antiproliferative Pt(IV) complexes: synthesis, biological activity, and quantitative structure-activity relationship modeling 140
Antiproliferative Activity of PtII Complexes with Carboxylated Phosphanes in Chelated or Ring-Opened Forms 135
Haemolymph from Mytilus galloprovincialis: Response to copper and temperature challenges studied by 1H-NMR metabonomics 135
13C Solid State MAS NMR spectra of [M3(CO)12] complexes (M = Ru and Os). Evidence for motional effects in [Ru3(CO)12] 135
Beyond the Pt(II)-based chemotherapy: Pt(IV) complexes as oral anticancer pro-drugs 134
Antioxidant Composition of a Selection of Italian Red Wines and Their Corresponding Free-Radical Scavenging Ability 134
The antiproliferative activity of dicobalt-hexacarbonyl-aspirin complex on different malignant pleural mesotelioma phenotypes 133
Assessment of the anticancer potentiality of a new platinum nanoparticulate coniugate 133
A different way for the oxidation of the Pt(II) complexes 131
A New Entry to Asymmetric Platinum(IV) Complexes via Oxidative Chlorination 130
Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 129
Different strategies to exploit Pt(IV) complexes as pro-drugs 128
Functionalized nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 128
Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs 127
Hybrid inorganic (nonporous silica)/organic (alginate) core-shell platform for targeting a cisplatin-based Pt(IV) anticancer prodrug 127
Water stability and cytotoxic activity relationship of a series of ferrocenium salts. characterization of the radical production during the degradation process. 125
1H-NMR SPIN-LATTICE RELAXATION STUDIES OF HYDRIDOMETAL CLUSTERS OF RUTHENIUM AND OSMIUM 125
Appraisal of the Redox Behaviour of the Antimetastatic Ruthenium(III) Complex [ImH][RuCl4(DMSO)(Im)], NAMI-A 124
Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: How long the organic chain should be? 123
199Hg NMR of mercury-bridged transition metal clusters 123
The cisplatin-based Pt(IV)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions 123
Moving the paradigm in platinum-based chemotherapy from Pt(II) to Pt(IV) complexes? 122
A multi-methodological inquiry of the behavior of cisplatin-based Pt(IV) derivatives in the presence of bioreductants with a focus on the isolated encounter complexes 122
Activation of alkynes by transition metals 121
ACTIVATION OF THE M-CO BOND IN TRANSITION-METAL COMPLEXES. FE2(CO)6(SME)2 AND PHOSPHINE-SUBSTITUTED DERIVATIVES AS GOOD CATALYSTS IN METAL-CARBONYL SUBSTITUTION-REACTIONS 121
Cis,cis,trans-[PtIVCl2(NH3)2(perillato)2], a dual-action prodrug with excellent cytotoxic and antimetastatic activity 121
17O NMR spectroscopy of transition metal carbonyls 120
Estradiol as Carrier For Selective Delivery of Cytotoxic Pt(II) Complexes to Cancer Cell Nuclei 120
Host-guest inclusion systems of Pt(IV)-bis(benzoato) anticancer drug candidates and cyclodextrins 120
Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer 120
Experimental (RP-HPLC) and theoretical (MIFs) study of the lipophilicity of a series of Pt(IV) complexes 119
Cytotoxicity of some Pt(II)-diamine complexes: a QSAR evaluation of the effect of chelating arms and leaving groups 119
An inspection into the class of bis(alkyne)-undecacarbonyl-quadro-tetraruthenium complexes. Crystal structure and dynamic behaviour of Ru4(CO)11 (μ4, η2-MeC2Ph)2 118
Antitumor platinum(IV) pro-drugs: synthesis, characterization, cytotoxicity and QSAR analysis 117
Effect of arbuscular mycorrhizal and bacterial inocula on nitrate concentration in mesocosms simulating a wastewater treatment system relying on phytodepuration 117
An unsymmetric cisplatin-based Pt(IV) derivative containing 2-(2-propynyl)octanoate: A very efficient multi-action antitumor prodrug candidate 117
Experimental and molecular modeling approaches to determine the lipophilicity of a Pt(IV) pro-drugs 116
A view on multi-action Pt(IV) antitumor prodrugs 116
Esr insights on the radical production during the degradation process relationship of some ferrocenium derivatives. Determination of their water stability and cytotoxic activity 115
May glutamine addiction drive the delivery of antitumor cisplatin-based Pt(IV) prodrugs? 115
A novel bonding scheme of an allene system in a transition metal cluster complex. Molecular structure of μ3-η-(1-methyl-3-ethyl-3-allenyl)-μ-hydrido-triangulo- tris(tricarbonylruthenium)(3Ru-Ru) 113
Esr insights on the radical production during the degradation process relationship of some ferrocenium derivatives. Determination of their water stability and cytotoxic activity 113
Polyanionic Biopolymers for the Delivery of Pt(II) Cationic Antiproliferative Complexes 113
New Platinum-Based Prodrug Pt(IV)Ac-POA: Antitumour Effects in Rat C6 Glioblastoma Cells 113
Effects of dimethylsulfoxide and ethanol on the cytotoxic activity of titanocene dichloride 112
Pros and cons of bifunctional platinum drugs: two are (not always) better than one 111
Bifunctional Pt-ethacrynic acid conjugates for malignant mesothelioma 110
Evaluation of Platinum–Ethacrynic Acid Conjugates in the Treatment of Mesothelioma 110
Wine Traceability with Rare Earth Elements 110
A MECHANISTIC STUDY OF THE REACTION OF H2OS3(CO)10 WITH TERMINAL ALKYNES 109
Electrochemical measurements confirm the preferential bonding of the antimetastatic complex [ImH][RuCl(4)(DMSO)(Im)] (NAMI-A) with proteins and the weak interaction with nucleobases 109
Solvolysis of a Series of Cisplatin-Like Complexes – Comparison between DNA-Biosensor and Conductivity Data 109
Authentication and traceability study of Hazelnuts from piedmont, italy 108
A 13C NMR investigation of stereochemical non rigidity in hydrido olefinic carbonyl clusters of ruthenium 108
Pt-195 NMR spectroscopy: A chemometric approach 107
Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin 107
Classical Pt(II) anticancer complexes revised in view of drug targeting and delivery 106
13C N.M.R. spectra of highly 13CO-enriched metal carbonyls: Observation of 2JCC cis coupling constants 106
Synthesis and characterization of cyclohexane-1R,2R-diamine-based Pt(iv) dicarboxylato anticancer prodrugs: their selective activity against human colon cancer cell lines 106
Water stability and cytotoxic activity relationship of a series of ferrocenium salts. characterization of the radical production during the degradation process 105
Cellular uptake of antitumor platinum(II)-complexes evaluated by means of ICP-MS technique 105
Synthesis, characterization and antiproliferative activity of platinum(IV) derivates of picoplatin 105
An experiment in the electrokinetic removal of copper from soil contaminated by the brass industry 104
Oxidative degradation of 1,5-naphthalenedisulfonic acid (NDS) in aqueous solutions by microwave irradiation in the presence of H2O2 104
Two are (not always) better than one: the case of bifunctional platinum(IV) drugs 104
Synthesis of PtIV-Biomolecule Conjugates through Click Chemistry 104
JQ1, a BET Inhibitor, Synergizes with Cisplatin and Induces Apoptosis in Highly Chemoresistant Malignant Pleural Mesothelioma Cells 103
Electronic Communication in [Co2(CO)6]2-diyne and [Co2(CO)4(dppm)]2-diyne Complexes 102
Antiproliferative effect of ferrocifen drug candidates on malignant pleural mesothelioma cell lines 102
The structures and fluxional behaviour of the binary carbonyls; A new approach. Part 3. The fluxional behaviour of [Fe3(CO)11L], L = PR3 or P(OR)3 101
Iron-57 satellites in 13C NMR spectra: an aid to elucidation of "hidden-processes" in the dynamics of metal carbonyls 100
Solution structure and dynamics of H2Ru4(CO)13 100
Cytotoxicity of cis-platinum(II) conjugate models. The effect of chelating arms and leaving groups on cytotoxicity: A quantitative structure-activity relationship approach 100
In vitro anti-mesothelioma activity of cisplatin–gemcitabine combinations: evidence for sequence-dependent effects 100
THERMAL AND PHOTOCHEMICAL BEHAVIOR OF ORGANOTETRARUTHENIUM CLUSTERS: SOLUTION STRUCTURES AND DYNAMICS OF PHOSPHINE-SUBSTITUTED DERIVATIVES 100
The effects of sulphur dioxide on wine metabolites: New insights from 1H NMR spectroscopy based in-situ screening, detection, identification and quantification 100
High-field 17O NMR spectroscopy: Solution structures and dynamics of 17O enriched Co4(CO)12 and HFeCo3(CO)12 99
Pt(IV) – histone deacetylase inhibitor conjugates for citotoxicity studies on MPM cells 99
The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells 99
13C-13C coupling constants in μ2- and μ4-(η2-acetylene) complexes of cobalt 99
Can the Self-Assembling of Dicarboxylate Pt(IV) Prodrugs Influence Their Cell Uptake? 99
Bioinorganic chemistry: the study of the fate of platinum-based antitumour drugs 98
Pt(IV) complexes as anticancer prodrugs 98
Unprecedented one-pot synthesis of an unsymmetrical cisplatin-based Pt(IV)-acetamidato complex 98
THE ALKYNE CLUSTER INTERACTION - STRUCTURAL, THEORETICAL, AND SPECTROSCOPIC STUDY ON THE PARALLEL μ3-η2 BONDING MODE IN TRINUCLEAR CARBONYL CLUSTERS OF RUTHENIUM AND OSMIUM 97
Metallo-drugs in the Treatment of Malignant Pleural Mesothelioma 97
Assessment of the in vivo antiproliferative activity of a novel platinum nanoparticulate pharmacophore 96
Assessment of the in vivo antiproliferative activity of a novel particulate pharmacophore 96
Isomerisation of Pentenes Catalysed by Ruthenium Cluster Carbonyls 96
Gas-phase UV photoelectron spectra of some edge-bridged decacarbonyltriosmium clusters 95
Oxidative degradation of 1,5-naphthalenedisulfonic acid in aqueous solutions by UV-photolysis in the absence and presence of H2O2 95
Molecular Interaction Fields vs. Quantum-Mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes 95
Wine evolution during bottle aging, studied by 1H NMR spectroscopy and multivariate statistical analysis 95
Electrochemical Behavior of the Electronically and Coordinatively Unsaturated [Os3(µ-H)(CO)8{Ph2PCH2P(Ph)C6H4}] Cluster 94
Totale 11.434
Categoria #
all - tutte 138.516
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 138.516


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021595 0 0 0 0 0 0 0 0 0 58 421 116
2021/20222.542 175 29 585 363 117 1 257 43 139 35 347 451
2022/20235.085 338 133 303 231 418 590 81 277 2.426 39 161 88
2023/20241.162 120 103 102 25 269 1 244 10 4 6 126 152
2024/20252.605 24 44 105 101 106 186 244 187 809 343 85 371
2025/20269.138 411 379 806 1.414 781 790 1.539 1.755 794 469 0 0
Totale 28.266